XVIVO (XVIVO) News
Follow XVIVO (XVIVO) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
XVIVO Q3 Revenue Beats Expectations on Thoracic Sales
EQUITY | Oct 22, 2026, 05:45 AM UTC
M
XVIVO Q3 Sales Rise 34% to SEK 252.6M
XVIVO reported Q3 2026 EBITDA of SEK 52.0M, a 21% margin, and EPS of SEK 1.42. The company also received CE certificates for its Heart Assist Transport System.
EARNINGS | Oct 22, 2026, 05:30 AM UTC
L
XVIVO Perfusion AB (publ) (XVIVO) Files PMA for Heart Assist Transport System With FDA
XVIVO Perfusion AB (publ) said the FDA has received its PMA application for the XVIVO Heart Assist Transport System, backed by the PRESERVE IDE trial and CAP data. The device is investigational in the US and not commerci
REGULATION | Sep 28, 2026, 09:01 AM UTC
M
XVIVO Granted Additional Patient Enrollment
XVIVO gets more patients for US study
EQUITY | Aug 03, 2026, 07:50 AM UTC